Search Results - "Mittman S"

Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.

Authors: Guan X Hu R Choi Y et al.

Source: Nature [Nature] 2024 Sep; Vol. 633 (8030), pp. E1.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; PubMed not MEDLINE

Index of Modern Authors.

Source: Aramaic Studies; 2010, Vol. 8 Issue 1/2, p173-177, 5p

The Proximity of PD-1 − CD103 + Tissue-Resident CD8 + T Cells to Tumor Cells Is Correlated with Improved Clinical Outcomes in Patients with Cholangiocarcinoma.

Authors: Li, Zhenyu Liu, Danping He, Jingjing et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p680. 17p.

TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation.

Authors: Nutsch K Banta KL Wu TD et al.

Source: Nature cancer [Nat Cancer] 2024 Dec; Vol. 5 (12), pp. 1834-1851. Date of Electronic Publication: 2024 Dec 16.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Diagnostic, Prognostic, and Predictive Molecular Biomarkers in Head and Neck Squamous Cell Carcinoma: A Comprehensive Review.

Authors: Michcik, Adam Wojciechowska, Barbara Tarnawski, Jakub et al.

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 2, p769. 17p.

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder.

Authors: Alexander, Laith Anderson, Dasha Baxter, Luke et al.

Source: British Journal of Pharmacology. Jul2026, Vol. 183 Issue 14, p3970-3991. 22p.

Beyond PD-1/PD-L1: Reprogramming the Gynecologic Tumor Microenvironment by Targeting TIGIT and Myeloid Suppression.

Authors: Waseem, Shanza Zhan, Jun Xiao, Xue

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 12, p5373. 25p.

The Architecture of Immune Escape in Neuroblastoma: Plasticity, Silence and Escape Engineer Immune Blindness.

Authors: Subramanian, Poorvi Periyasamy, Loganayaki Mohanvelu, Sreenidhi et al.

Source: Cells (2073-4409). Jun2026, Vol. 15 Issue 12, p1072. 73p.

The Double-Edged Sword: How Radiotherapy Shapes the Tumor Immune Microenvironment to Modulate Responses to Checkpoint Inhibitors.

Authors: Chiang, Chen-Hsuan Chan, Hui-Wen Chuang, Hui-Yen

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 10, p4525. 19p.

C-Terminus of Ca v 1.3 L-Type Ca 2+ Channel Upregulates Its Own Gene Expression.

Authors: Sleiman, Yvonne Srivastava, Ujala Reisqs, Jean-Baptiste et al.

Source: Cells (2073-4409). May2026, Vol. 15 Issue 9, p828. 25p.

Research priority setting for implementation science and practice: a living systematic review protocol.

Authors: Zhao, Junqiang Chen, Wenjun Bai, Wenhui et al.

Source: Systematic Reviews. 2/28/2025, Vol. 14 Issue 1, p1-7. 7p.

SARS-CoV-2 Infection Alters the Immune Microenvironment in Lung Cancer Patients Undergoing Immunotherapy and Affects Treatment Outcomes.

Authors: Peng, Yanjing Wei, Panjian Gu, Meng et al.

Source: Viruses (1999-4915). Oct2025, Vol. 17 Issue 10, p1314. 15p.

Multidimensional comparative evaluation of first-line therapies for extensive-stage small cell lung cancer: a systematic review and network meta-analysis of clinical efficacy and safety profiles.

Authors: Jiang, Ziyao Zhao, Fangrui Li, Butuo et al.

Source: BMC Cancer. 8/9/2025, Vol. 25 Issue 1, p1-13. 13p.

Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion.

Authors: Harrer, Dennis Christoph Schlierkamp-Voosen, Tim Barden, Markus et al.

Source: Cells (2073-4409). Jun2025, Vol. 14 Issue 12, p901. 14p.

Emerging CRISPR Approaches for Countering Immune Evasion: Insight from Recent Studies.

Authors: Abubakar, Sadam Abdulsalam, Latifat Fatty, Lamin et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 7, p2930. 31p.

TIGIT Blockade Potentiates the Anti-Leukemic Activity of Exercise-Mobilized Donor Lymphocytes and Expanded γδ T-Cells.

Authors: McKenzie, Grace M. Voss, Josie Katsanis, Emmanuel et al.

Source: Cancers. Mar2026, Vol. 18 Issue 5, p797. 20p.

CCR8 antagonist suppresses liver cancer progression via turning tumor-infiltrating Tregs into less immunosuppressive phenotype.

Authors: Tian, Binle Wang, Zhilong Cao, Mei et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 4/4/2025, Vol. 44 Issue 1, p1-19. 19p.

Lidocaine Modulates Cytokine Production and Reprograms the Tumor Immune Microenvironment to Enhance Anti-Tumor Immune Responses in Gastric Cancer.

Authors: Wu, Yi-Ying Chen, Ming-Shan Chen, I-Chun et al.

Source: International Journal of Molecular Sciences. Apr2025, Vol. 26 Issue 7, p3236. 23p.

cGAS and STING in Host Myeloid Cells Are Essential for Effective Cyclophosphamide Treatment of Advanced Breast Cancer.

Authors: Lai, Yein-Gei Liao, Hao-Ting Chen, Yung-Hsiang et al.

Source: Cancers. Apr2025, Vol. 17 Issue 7, p1130. 17p.

EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer.

Authors: Zhou, Jiefu He, Min Zhao, Qiong et al.

Source: Molecular Cancer. 3/22/2025, Vol. 24 Issue 1, p1-26. 26p.